
Big Brothers Big Sisters of Orange County goes big with a new mural
The new billboard-sized artwork is meant to catch the eye of the more than 100,000 drivers motoring past the organization's building each day. Sloane Keane, chief executive officer at Big Brothers Big Sisters of Orange County & Inland Empire, hopes the work will not only touch the young people the organization serves, but also highlight the life-changing impact mentorship can have and inspire people to volunteer.
'We wanted this mural to be two things: a piece of art and also a call to action to the community,' Keane said to the crowd at the mural unveiling ceremony.
Big Brothers Big Sisters of Orange County & Inland Empire is a mentorship program serving at-risk youth, especially those from low-income households who are in need of positive role models. The organization works to match young boys and girls with a mentor through multiple professionally-supported programs the nonprofit offers. According to BBBS, nearly 65% of the population they serve live below the poverty line and low-income youth are nearly 10 times more likely to drop out of school.
By partnering youth (or 'Littles') with a positive role model who provides a mentoring relationship (a 'Big'), BBBS increases the chance of a successful academic career for the child. 'Littles' who participate in Big Brothers Big Sisters have a 98% success rate of graduating from high school and almost 67% go on to be the first to graduate from college in their family.
For the mural, the organization tapped local artist, Carla Roque.
'I love to create murals that bring a little bit of joy to the communities that they are created in,' Roque said.
Against the BBBS logo, a Latino child, or a 'Little,' wearing glasses looks up at his 'Big' mentor, whose face isn't visible to the viewer. Viewers can infer from the wide smile and shining eyes of the youngster that he feels the adult is someone he can look up to and admire. Yellow rays emphasize the boy's line of vision toward his mentor and more details around the man's hand on the boy's shoulder demonstrate the powerful connection between the two of them. 'It takes little to be BIG,' the mural reads.
Roque said she worked hard to include culturally specific features that would help members of the community feel represented in the work.
'We were really looking to make sure the community saw themselves in the mural, that was something that fit within this space of who they are, especially calling out male mentors for young Hispanic males. There is a huge need for that in this area,' said Roque. 'The little things like the gold chain were details that people in the community would notice and feel seen.'
The Fullerton-based artist has been working in the community for 25 years, primarily creating murals. For this recent work she employed the help of seven pairs of 'Bigs' and 'Littles,' giving mentors and mentees the opportunity to take part in the creative process.
Keane said it was also important for the organization to show two males in the mural.
'This is a reminder to the community to get involved, particularly men. We are looking for men,' said Keane. 'We have over 100 little boys today waiting for a positive male role model to be introduced into their life.'
Keane said the two words on the bottom of the mural, 'Volunteer' and 'Donate,' are meant to inspire action.
'Those are the two most important resources this organization needs. Everybody needs funding but in equal measure we need volunteers to walk through the door and stand up and mentor,' said Keane.
For donation and volunteer opportunities with Big Brothers Big Sisters of Orange County & Inland Empire visit ocbigs.org.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Epoch Times
an hour ago
- Epoch Times
The Hidden Math That Makes Some Australians Poorer for Working Harder
AD It may seem counterintuitive, but working longer hours can make you less money, the e61 Institute says. A pile of bills in Brisbane, Australia, on Oct. 30, 2013. AAP Image/Dan Peled 8/13/2025 | Updated: 8/13/2025 Not so long ago, working harder was thought to guarantee you were better off. Rex Widerstrom is a New Zealand-based reporter with over 40 years of experience in media, including radio and print. He is currently a presenter for Hutt Radio. Author's Selected Articles


Business Upturn
an hour ago
- Business Upturn
Indoco Remedies gets USFDA nod for generic Rivaroxaban tablets; eyes growth in US Market
Mumbai-based Indoco Remedies Ltd. has secured final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to market Rivaroxaban Tablets USP in strengths of 2.5 mg, 10 mg, 15 mg, and 20 mg. The product is the generic equivalent of Janssen Pharmaceuticals' blockbuster anticoagulant, Xarelto, and will be manufactured at Indoco's Verna, Goa facility. The approved Rivaroxaban tablets are bioequivalent and therapeutically equivalent to Xarelto and are indicated for the treatment of venous thromboembolism (VTE). This approval marks another milestone in Indoco's push into the US generics market, one of the most lucrative pharmaceutical markets globally. Commenting on the development, Indoco Remedies' Managing Director Aditi Panandikar said, 'Besides reflecting the capability of Indoco Remedies to deliver products of high-quality standards, this development also provides impetus to our growth aspirations in an important market such as the US.' Indoco Remedies is a fully integrated, research-driven pharmaceutical company with a global footprint, generating over 106 million prescriptions annually in India alone. The company operates 11 manufacturing facilities — seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs) — all of which are approved by top global regulatory agencies including the USFDA and UK-MHRA. With a turnover of $180 million and a workforce of more than 6,000 employees, Indoco is known for popular domestic brands such as Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, and Cital. Internationally, the company partners with large generics players to expand its market reach across multiple geographies. The latest USFDA approval strengthens Indoco's product portfolio in the regulated market and could open up significant revenue opportunities as Rivaroxaban continues to be a widely prescribed oral anticoagulant in the US. Disclaimer: This news article is for informational purposes only and does not constitute investment advice. Investors should consult a qualified financial advisor before making investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.


Business Upturn
2 hours ago
- Business Upturn
Honasa Consumer surges over 8% after Q1 earnings beat and brokerage upgrades
By Aditya Bhagchandani Published on August 13, 2025, 09:24 IST Shares of Honasa Consumer Ltd., the parent company of Mamaearth, surged 8.15% to ₹291.25 on Wednesday, August 13, following the announcement of its June quarter (Q1 FY26) results after market hours on Tuesday. This marks the second consecutive session of gains for the stock. The company posted a net profit of ₹41 crore for Q1 FY26, up 2.7% year-on-year, while revenue grew 7% YoY to ₹595 crore. EBITDA slipped 1% YoY to ₹46 crore, with margins holding at 7.7%. Hong Kong-based brokerage CLSA upgraded Honasa to 'Outperform' and raised its price target to ₹333, noting Q1 revenue growth of 7.4% YoY in line with expectations, alongside underlying volume growth of 10.5% YoY. CLSA highlighted a sequential EBITDA margin expansion of 264 bps to 7.7%, delivering a 47% beat versus its estimates and a 44% beat on consensus expectations. Management guided for an EBITDA margin of around 7% in FY26, with 100-150 bps expansion annually over the next 4–5 years. CLSA also raised its FY26–FY28 earnings estimates by 15–26%. Jefferies maintained a 'Buy' rating with a price target of ₹400, citing positive margin surprises. The brokerage acknowledged that unseasonal rains impacted sunscreen sales but noted that sequential EBITDA margin improvement and outperformance versus expectations were key positives. Jefferies added that while new brands are scaling slowly, Mamaearth remains the primary growth driver. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.